BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2011
View Archived Issues
Sulfated hyaluronic acid shows preclinical promise to treat prostate cancer
Read More
Johnson & Johnson discloses new adenosine A2A receptor antagonists
Read More
Halozyme Therapeutics presents recombinant human proteins with collagenolytic effects
Read More
New glucocorticoid receptor modulators prepared
Read More
Vantia presents novel kallikrein-1 inhibitors
Read More
Allopurinol may improve outcomes in patients with ischemic stroke
Read More
Johnson & Johnson claims novel delta opioid receptor ligands
Read More
New lysophospholipid LPA1 receptor antagonists prepared at sanofi-aventis
Read More
Kaken Pharmaceutical obtains approval in Japan for additional doses and indication of Ebutol
Read More
InSite Vision reaches SPA agreement with FDA for phase III trial of AzaSite Plus and DexaSite
Read More
Peregrine Pharmaceuticals begins bavituximab combination trial in prostate cancer
Read More
Tigris Pharmaceuticals begins phase II trial of AFP-464 in ER-positive breast cancer
Read More
Eszopiclone effectively treats insomnia as add-on to escitalopram in GAD and to fluoxetine in MDD
Read More
TD-1211 safety and pharmacokinetics assessed in healthy volunteers and patients with OIC
Read More
Isconova begins phase I trial of its Matrix M adjuvant with seasonal influenza vaccine
Read More
Pharmasset begins phase IIa PSI-7977/daclatasvir study for hepatitis C genotypes 1, 2 and 3
Read More
MAP Pharmaceuticals submits NDA for Levadex to FDA
Read More
Epitomics signs agreement with Bayer Schering Pharma for antibody technology
Read More
EMA accepts for review Savient Pharmaceuticals' MAA for Krystexxa
Read More
Medicago to collaborate with U.S. army on Ebola vaccine
Read More
Mitsubishi Tanabe Pharma launches antiallergy agent bepotastine besilate in China and Indonesia
Read More
Sanofi and DNDi enter 3-year collaboration to research nine neglected tropical diseases
Read More
U.S. government requests proposal from Emergent BioSolutions for supply BioThrax anthrax vaccine
Read More
EMA and Health Canada recommend revaccination with Ixiaro vaccine due to batch recall
Read More
FDA approves Dificid for treatment of CDI-associated diarrhea
Read More